269 related articles for article (PubMed ID: 8630621)
1. Muscle weakness in mechanically ventilated patients with severe asthma.
Leatherman JW; Fluegel WL; David WS; Davies SF; Iber C
Am J Respir Crit Care Med; 1996 May; 153(5):1686-90. PubMed ID: 8630621
[TBL] [Abstract][Full Text] [Related]
2. Prolonged neuromuscular blockade in two critically ill patients treated with atracurium.
Hoey LL; Joslin SM; Nahum A; Vance-Bryan K
Pharmacotherapy; 1995; 15(2):254-9. PubMed ID: 7624274
[TBL] [Abstract][Full Text] [Related]
3. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
[TBL] [Abstract][Full Text] [Related]
4. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids.
Barohn RJ; Jackson CE; Rogers SJ; Ridings LW; McVey AL
Muscle Nerve; 1994 Jun; 17(6):647-54. PubMed ID: 7910951
[TBL] [Abstract][Full Text] [Related]
5. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
Frankel H; Jeng J; Tilly E; St Andre A; Champion H
Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
[TBL] [Abstract][Full Text] [Related]
6. The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
May JR; Rutkowski AF
J Med Assoc Ga; 1994 Aug; 83(8):473-6, 484. PubMed ID: 7822974
[TBL] [Abstract][Full Text] [Related]
7. The incidence of residual neuromuscular blockade associated with single dose of intermediate-acting neuromuscular blocking drugs.
Kaan N; Kocaturk O; Kurt I; Cicek H
Middle East J Anaesthesiol; 2012 Feb; 21(4):535-41. PubMed ID: 23327026
[TBL] [Abstract][Full Text] [Related]
8. Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids.
Behbehani NA; Al-Mane F; D'yachkova Y; Paré P; FitzGerald JM
Chest; 1999 Jun; 115(6):1627-31. PubMed ID: 10378560
[TBL] [Abstract][Full Text] [Related]
9. [Prolonged paralysis after long-term administration of vecuronium in the intensive care unit].
Tanaka O; Akai H; Takekida S; Tanaka Y; Wake M; Iijima K; Horikawa Y; Ijichi K
Masui; 2006 Aug; 55(8):992-4. PubMed ID: 16910480
[TBL] [Abstract][Full Text] [Related]
10. Myopathy in severe asthma.
Douglass JA; Tuxen DV; Horne M; Scheinkestel CD; Weinmann M; Czarny D; Bowes G
Am Rev Respir Dis; 1992 Aug; 146(2):517-9. PubMed ID: 1362636
[TBL] [Abstract][Full Text] [Related]
11. Prolonged reversible quadriparesis in mechanically ventilated patients who received long-term infusions of vecuronium.
Margolis BD; Khachikian D; Friedman Y; Garrard C
Chest; 1991 Sep; 100(3):877-8. PubMed ID: 1679710
[TBL] [Abstract][Full Text] [Related]
12. Persistent paralysis after prolonged use of atracurium in the absence of corticosteroids.
Rubio ER; Seelig CB
South Med J; 1996 Jun; 89(6):624-6. PubMed ID: 8638206
[TBL] [Abstract][Full Text] [Related]
13. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
[TBL] [Abstract][Full Text] [Related]
14. [Respiratory muscle weakness after prolonged use of hydrocortisone and pancuronium bromide].
Koishi K; Ooe Y; Hirata A; Kimura H; Izawa M
Masui; 2000 Jan; 49(1):72-4. PubMed ID: 10689850
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection.
Clarens DM; Kelly KJ; Gilliland SS; Kohls PK; Nahum A; Vance-Bryan K
Pharmacotherapy; 1993; 13(6):647-55. PubMed ID: 7905621
[TBL] [Abstract][Full Text] [Related]
16. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium.
Berg H; Roed J; Viby-Mogensen J; Mortensen CR; Engbaek J; Skovgaard LT; Krintel JJ
Acta Anaesthesiol Scand; 1997 Oct; 41(9):1095-1103. PubMed ID: 9366929
[TBL] [Abstract][Full Text] [Related]
17. Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
Buck ML; Reed MD
Clin Pharm; 1991 Jan; 10(1):32-48. PubMed ID: 1825627
[TBL] [Abstract][Full Text] [Related]
18. Acute quadriparesis in an asthmatic treated with atracurium.
Tousignant CP; Bevan DR; Eisen AA; Fenwick JC; Tweedale MG
Can J Anaesth; 1995 Mar; 42(3):224-7. PubMed ID: 7743575
[TBL] [Abstract][Full Text] [Related]
19. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S
Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
[TBL] [Abstract][Full Text] [Related]
20. Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusion.
de Lemos JM; Carr RR; Shalansky KF; Bevan DR; Ronco JJ
Crit Care Med; 1999 Dec; 27(12):2648-55. PubMed ID: 10628604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
